These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27175717)

  • 21. Efficacy and Safety of Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Women: A Systematic Review and Meta-analysis.
    Jaspers L; Feys F; Bramer WM; Franco OH; Leusink P; Laan ET
    JAMA Intern Med; 2016 Apr; 176(4):453-62. PubMed ID: 26927498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
    Thorp J; Palacios S; Symons J; Simon J; Barbour K
    BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder: A Systematic Review and Meta-Analysis.
    Gao Z; Yang D; Yu L; Cui Y
    J Sex Med; 2015 Nov; 12(11):2095-104. PubMed ID: 26745616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Flibanserin as pharmacological therapy of inhibited sexual desire in women].
    Eldon AS; Giraldi A
    Ugeskr Laeger; 2017 Feb; 179(7):. PubMed ID: 28397671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Sep; 57(1478):133-5. PubMed ID: 26375434
    [No Abstract]   [Full Text] [Related]  

  • 26. Addendum: Flibanserin (Addyi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):156. PubMed ID: 26529137
    [No Abstract]   [Full Text] [Related]  

  • 27. Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder.
    Stahl SM; Sommer B; Allers KA
    J Sex Med; 2011 Jan; 8(1):15-27. PubMed ID: 20840530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Flibanserin in Women Treated With Antidepressants: A Randomized, Placebo-Controlled Study.
    Clayton AH; Croft HA; Yuan J; Brown L; Kissling R
    J Sex Med; 2018 Jan; 15(1):43-51. PubMed ID: 29289374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Circle of Female Sexual Desire-Have We Come a Long Way?
    Katz A
    Nurs Womens Health; 2016; 20(3):235-8. PubMed ID: 27287350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flibanserin Ineffective for Hypoactive Sexual Desire Disorder in Women.
    Shaughnessy AF
    Am Fam Physician; 2016 Sep; 94(5):384-6. PubMed ID: 27583427
    [No Abstract]   [Full Text] [Related]  

  • 31. Flibanserin: From Bench to Bedside.
    Dooley EM; Miller MK; Clayton AH
    Sex Med Rev; 2017 Oct; 5(4):461-469. PubMed ID: 28757356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of flibanserin in managing hypoactive sexual desire disorder in women: A systematic review and meta-analysis.
    Kamrul-Hasan ABM; Hannan MA; Alam MS; Aalpona FTZ; Nagendra L; Selim S; Dutta D
    Medicine (Baltimore); 2024 Jun; 103(25):e38592. PubMed ID: 38905407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC; Zanolla Dias de Souza K; Rezende CR; Geber S
    Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
    Puppo G; Puppo V
    Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
    [No Abstract]   [Full Text] [Related]  

  • 35. Flibanserin - the female Viagra?
    Shapiro D; Stevens D; Stahl SM
    Int J Psychiatry Clin Pract; 2017 Nov; 21(4):259-265. PubMed ID: 28434386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First Pharmacological Therapy for Hypoactive Sexual Desire Disorder in Premenopausal Women: Flibanserin.
    Robinson K; Cutler JB; Carris NW
    Ann Pharmacother; 2016 Feb; 50(2):125-32. PubMed ID: 26692273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex, drugs, and rhetoric: The case of flibanserin for 'female sexual dysfunction'.
    Segal JZ
    Soc Stud Sci; 2018 Aug; 48(4):459-482. PubMed ID: 29862892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ignorance Is Not Bliss: If We Don't Understand Hypoactive Sexual Desire Disorder, How Can Flibanserin Treat It? Commentary.
    Anderson R; Moffatt CE
    J Sex Med; 2018 Mar; 15(3):273-283. PubMed ID: 29396022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
    Jayne C; Simon JA; Taylor LV; Kimura T; Lesko LM;
    J Sex Med; 2012 Dec; 9(12):3180-8. PubMed ID: 23057791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flibanserin.
    Vallejos X; Wu C
    J Pharm Pract; 2017 Apr; 30(2):256-260. PubMed ID: 26873507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.